Summary
Biotech SME in Hungary (representative of the Thai mother company) applying patented liposomal nanotechnology for production of new generation dietary-supplements for human and animal consumption is offering its manufacturing service. The company has more than 200 ingredients (more than 50 liposomal) and can do all type of dry and oil formulations in its fully automated high-tech factory. The company is looking for outsourcing/manufacturing agreement.
Description
The Hungarian SME is a modern dietary supplement company specializing in the development and production of a wide range of products made from natural ingredients.
The biotech company is one of the few in the world, who is actively developing and applying liposomal nanotechnology on production scale. It is operating at over 10,000 square meters facilities, which are partially powered by solar energy. The company has more than 60 self-developed products to be sold by partners under private or white labeling, but on unique requests the company manufactures liposomal dietary-supplements with the help of its 206 ingredients. It has the technology to produce liposomes with almost all kind of ingredients. It can offer development services as well, its R&D department constantly carrying research in the field of biotech nanotechnology.
The company develops products for both human and animal use in the field of applied medicine and clinical nutrition, and is also capable of producing liposomal raw materials in the form of dry powders or nanoemulsions, as well as products in the form of tablets, capsules, sachets and oils.
The technology allows the production of any formulation: Dry formulations (all kind of mono-, bi- and tri-layered tablets, chewable tablets, effervescent tablets, hard capsules, stick sachets, bi- sachets, zipper bags, jars) and oil formulations (hard capsules, ampoules, bottles, soft gels).
The company offers full support to clients in the field of: research and product development, production, packaging and logistics.
The SME is offering its manufacturing capacity in the frame of an outsourcing/ manufacturing agreement.